MRP ₹85
(Inclusive of all Taxes)
₹12.8 Cashback (15%)
Provide Delivery Location
About Fibractiv 35 Tablet
Fibractiv 35 Tablet is used to treat increased cholesterol levels or fat/oils. Hyperlipidemia is a condition in which there is a high level of low-density lipoproteins (LDL) or bad cholesterol and a decreased level of high-density lipoprotein (HDL) or good cholesterol.
Fibractiv 35 Tablet contains fenofibrate, which works by increasing the natural substance that breaks down fats in the bloodstream, thereby increasing its utilization and removal. As a result, Fibractiv 35 Tablet decreases harmful cholesterol like LDL (bad cholesterol) and triglycerides (TG) and increases levels of HDL (good cholesterol).
Some people may experience nausea, chest pain, vomiting, diarrhoea, drowsiness, muscle pain, redness/swelling in the legs and increased liver enzymes. Most of these side effects of Fibractiv 35 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Do not use Fibractiv 35 Tablet without a doctor's advice if you have a skin reaction or irritation to any medicine. Consult your doctor before using Fibractiv 35 Tablet if you are pregnant or breastfeeding. Fibractiv 35 Tablet is not recommended for children under the age of 18, as the safety and effectiveness were not established. Avoiding alcohol is recommended to rule out any possibility of side effects.
Uses of Fibractiv 35 Tablet
Fibractiv 35 Tablet is used to manage high lipid levels and lower the risk of cardiovascular problems. The detailed uses of Fibractiv 35 Tablet are as follows:

Have a query?
Directions for Use
Key Benefits
How Fibractiv 35 Tablet Works
Storage
What if I have taken an overdose of Fibractiv 35 Tablet
Drug Warnings
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Safe if prescribed
Avoid drinking alcohol as it can raise liver enzymes and liver functions test (LFT), thereby damaging your liver.
Pregnancy
Consult your doctor
Fibractiv 35 Tablet is a Category C risk medicine; talk with your doctor if you’re pregnant or planning to become pregnant. Fibractiv 35 Tablet should be used only if the potential benefit justifies the potential risk.
Breast Feeding
Consult your doctor
Fibractiv 35 Tablet should not be used in nursing mothers unless clearly necessary. So, inform your doctor if you are a nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Fibractiv 35 Tablet .
Driving
Safe if prescribed
Fibractiv 35 Tablet does not impact your ability to drive or operate machinery.
Liver
Consult your doctor
Caution is advised. If you have/had liver problems, your doctor may need to monitor your liver function.
Kidney
Consult your doctor
Fibractiv 35 Tablet should not be used in severe kidney problems, including in patients on dialysis. However, mild to moderate kidney patients can use Fibractiv 35 Tablet if prescribed by the doctor.
Children
Safe if prescribed
Fibractiv 35 Tablet is not recommended for children under the age of 18.
Heart
Fibractiv 35 Tablet is often prescribed to patients with heart problems to manage high cholesterol and reduce cardiovascular risk. However, it must be taken strictly under medical supervision, as it can affect liver and kidney function and may interact with other heart medications.
Geriatrics
Consult your doctor
Fibractiv 35 Tablet should be used under extreme caution in geriatric patients. Please consult your physician.
Fibractiv 35 Tablet is used to treat raised or increased cholesterol levels or fat/oils.
Fibractiv 35 Tablet contains fenofibrate, which works by‚ increasing the natural substance that breaks down fats in the bloodstream, thereby increasing its utilization and removal. As a result, Fibractiv 35 Tablet decreases harmful cholesterol like LDL (bad cholesterol) and triglycerides (TG) and increases‚ levels of HDL (good cholesterol).
You should not take Fibractiv 35 Tablet if you are allergic to fibric acid derivative or Fibractiv 35 Tablet , have a severe renal impairment (including dialysis patient), have active liver disease, gallbladder disease (gallstone) or are a nursing mother.
Increased liver enzymes (like liver function tests - LFTs), rhinitis, stuffy/runny nose, nausea, indigestion, headache and back pain are some common side effects that may occur in some cases.
No, Fibractiv 35 Tablet does not reduce the risk of having heart problems in patients with type 2 diabetes.
Long-term complications of Fibractiv 35 Tablet are muscle problems (like unexplained muscle pain) and liver problems (with increased liver enzymes). So, if you experience these symptoms, please consult a doctor.
Fibractiv 35 Tablet raises the risk of muscle pain and a serious muscle problem called rhabdomyolysis. The risk is higher if you take the drug along with statins.
It is completely fine to use oral contraceptives with Fibractiv 35 Tablet as no such interactions have been found. Consult your doctor for further advice.
If you forget to take a dose of Fibractiv 35 Tablet , take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
Do not take more than the prescribed dose of Fibractiv 35 Tablet , as it may cause an overdose. If you suspect you have taken an overdose, please consult a doctor immediately.
While specific dosing instructions will vary depending on your individual needs and medical history. Always follow your doctor's prescribed dosage and timing for taking these medications.
Avoid drinking alcohol as Fibractiv 35 Tablet can raise liver enzymes, thereby damaging your liver.
Periodic monitoring of red and white blood cell counts is recommended during the first 12 months of Fibractiv 35 Tablet administration.
Fibractiv 35 Tablet may cause liver damage and inflammation after years of use.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information